EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Verisoul
start up
United States
- Austin, Texas
- 17/12/2025
- Series A
- $8,800,000
Verisoul is the ultimate platform for stopping fake accounts. From multi-accounting detection and AI fraud decisioning to bot & deepfake prevention, Verisoul is the all-in-one solution designed to automate fake account defense and help you grow faster and healthier. Stay one step ahead of fraud with Verisoul.
Businesses that switch to Verisoul replace an average of 4 other vendors, spend 32% less, and detect >95% fake/bot accounts. It's why customers call us "The Holy Grail" of fraud prevention.
- Industry Technology, Information and Internet
- Website https://www.verisoul.ai/
- LinkedIn https://www.linkedin.com/company/verisoul-stops-fake-accounts/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)